Virtual screening and experimental validation reveal novel small-molecule inhibitors of 14-3-3 protein-protein interactions

Philipp Thiel, Lars Röglin, Nicole Meissner, Sven Hennig, Oliver Kohlbacher, Christian Ottmann

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

We report first non-covalent and exclusively extracellular inhibitors of 14-3-3 protein-protein interactions identified by virtual screening. Optimization by crystal structure analysis and in vitro binding assays yielded compounds capable of disrupting the interaction of 14-3-3σ with aminopeptidase N in a cellular assay.

Original languageEnglish
Pages (from-to)8468-70
Number of pages3
JournalChemical Commununications
Volume49
Issue number76
DOIs
Publication statusPublished - 4 Oct 2013
Externally publishedYes

Keywords

  • 14-3-3 Proteins
  • Dose-Response Relationship, Drug
  • Fibroblasts
  • High-Throughput Screening Assays
  • Humans
  • Lung
  • Matrix Metalloproteinase 1
  • Models, Molecular
  • Molecular Structure
  • Protein Binding
  • RNA, Messenger
  • Small Molecule Libraries
  • Structure-Activity Relationship
  • Up-Regulation
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Virtual screening and experimental validation reveal novel small-molecule inhibitors of 14-3-3 protein-protein interactions'. Together they form a unique fingerprint.

Cite this